| Accession |
PRJCA016519 |
| Title |
A Phase II clinical study to evaluate the clinical efficacy and safety of HLX10 combined with HLX07 in patients with advanced head and neck tumors |
| Relevance |
Medical |
| Data types |
PK and ADA
|
| Organisms |
Homo sapiens
|
| Description |
A Phase II clinical study to evaluate the clinical efficacy and safety of HLX10 (recombinant anti-PD-1 humanized monoclonal antibody) combined with HLX07 (recombinant anti-EGFR humanized monoclonal antibody) in patients with advanced head and neck tumors |
| Sample scope |
Multiisolate |
| Release date |
2023-04-25 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Li
Jin (lijin@csco.org.cn)
|
| Organization |
Shanghai East Hospital |
| Submission date |
2023-04-24 |
